<DOC>
	<DOCNO>NCT02461732</DOCNO>
	<brief_summary>The purpose study determine whether novel integrate cognitive-behavioral treatment posttraumatic stress disorder ( PTSD ) substance dependence ( i.e. , Treatment Integrated Posttraumatic Stress Substance use ; TIPSS ) effective cognitive-behavioral treatment substance dependence alone regard PTSD symptom substance use quantity frequency .</brief_summary>
	<brief_title>Trial Novel Cognitive-Behavioral Treatment Posttraumatic Stress Substance Dependence</brief_title>
	<detailed_description>The propose study randomize controlled clinical trial , compare efficacy two cognitive-behavioral therapy ( CBT ) intervention : standard CBT substance dependence novel integrate CBT program PTSD substance dependence . The study run approximately 3 year . A total 100 participant enrol rate 4 participant per month 25 month ensure 80 participant complete protocol ( presume 20 % attrition ) . Each participant attend 12 treatment session , meet twice per week 6 week . Treatment session last 1-hour . Primary study outcome include frequency quantity substance use PTSD symptom severity . Substance use-related outcome include : rate substance abstinence , measure ( 1 ) urine toxicology testing , ( 2 ) alcohol breath level analysis , ( 3 ) participant ' self-report substance use . PTSD symptom outcome include symptom severity rating measure clinical interview ( i.e. , Clinician-Administered PTSD Scale-5 ; CAPS-5 ) self-report ( Posttraumatic Checklist ; PCL-5 ) . Secondary study outcome include examination mediational effect . Specifically , change distress tolerance , indexed via self-report ( Distress Tolerance Scale ) computer/behavioral task ( i.e. , Mirror-Tracing Task , Paced Auditory Serial Addition Task-Computerized Version , Breath-Holding Task ) , expect course treatment . Changes cue reactivity also expect course treatment , index decreased psychophysiological reactivity ( heart rate , respiration rate ) script-driven imagery task ( listen trauma/drug relate script vs. netural ) . A total four session ( baseline/screening session 4 , 8 , 12 ) precede laboratory session .</detailed_description>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<criteria>Age 1865 English language proficiency Current ( past month ) substance dependence , note exclusion delineate History trauma exposure , per DSM5 Criterion A1 definition Current ( past month ) PTSD symptom : score least 25 PCL5 and/or least 4 symptom moderate severity ( score 2 high ) endorse CAPS5 Seeking treatment traumarelated symptom substance dependence Exclusive [ ] nicotine dependence Alcohol dependence require detoxification Opiate dependence require detoxification Current past bipolar I disorder Current past major psychotic disorder Active ( past 6 month ) psychotic spectrum symptom Major unstable medical condition Current ( past month ) suicidal ideation intent and/or plan Current ( past month ) homicidal ideation intent and/or plan Inability provide verbal/written consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>posttraumatic stress disorder</keyword>
	<keyword>PTSD</keyword>
	<keyword>substance dependence</keyword>
	<keyword>substance use</keyword>
</DOC>